College of Food Science and Technology, Nanjing Agricultural University, Nanjing 210095, People's Republic of China.
Food Funct. 2021 Aug 2;12(15):6964-6980. doi: 10.1039/d1fo00534k.
Natural biological macromolecules with putative functions of gut microbiota regulation possess the advantage of improving metabolic syndrome (MS). In this research, we aimed to determine the effects of Flammulina velutipes polysaccharide (FVP) (Expt. 1) and fecal microbiota transplantation (FMT) (Expt. 2) on MS-related disorders, gut microbiota structure changes and their underlying mechanisms in a murine model fed with high-fat diet (HFD). In Expt. 1, six-week-old male C57BL/6J mice were fed with a control diet (10% calories from fat) or a high fat diet (45% calories from fat), administered with saline or FVP (0.4 mg per g b.w.) by gavage over a 12-week period. In Expt. 2, mice were fed with a HFD, administered with fecal supernatants from healthy and FVP-fed donor mice for 12 weeks simultaneously. The body mass, blood lipid levels and blood glucose homeostasis of mice were analyzed, and total RNA from mouse liver and adipose tissue were extracted by TRIzol and the lipid metabolism-related gene expressions were calculated by qRT-PCR. Gut microbiota changes were evaluated by high-throughput sequencing. Results indicated that FVP and FMT supplementations showed an attenuation effect on mouse obesity, hyperlipidemia and insulin resistance. Up-regulated expressions of Ampkα1 and Ppara were found both in FVP and FMT treatment groups. Different changes were found in the gut microbiota caused by FVP and FMT, respectively. PICRUSt analysis indicated that compared with FVP supplementation, FMT showed a significant effect on regulating lipid metabolism in HFD-fed mice. The findings from this study indicated that oral administrations of FVP or FMT could significantly attenuate MS-related obesity, hyperlipidemia and insulin resistance in HFD-fed mice, and the beneficial effects may be mediated through lipid metabolism and gut microbiota regulation in different ways. These results improve the understanding of the functional activity of FVP as prebiotics.
具有调节肠道微生物群功能的天然生物大分子具有改善代谢综合征(MS)的优势。在这项研究中,我们旨在确定金针菇多糖(FVP)(实验 1)和粪便微生物群移植(FMT)(实验 2)对高脂肪饮食(HFD)喂养的小鼠模型中与 MS 相关的疾病、肠道微生物群结构变化及其潜在机制的影响。在实验 1 中,6 周龄雄性 C57BL/6J 小鼠喂食对照饮食(10%热量来自脂肪)或高脂肪饮食(45%热量来自脂肪),同时通过灌胃给予生理盐水或 FVP(0.4mg/g b.w.)12 周。在实验 2 中,小鼠喂食 HFD,同时给予健康和 FVP 喂养供体小鼠的粪便上清液 12 周。分析小鼠的体重、血脂水平和血糖稳态,并通过 TRIzol 提取小鼠肝脏和脂肪组织的总 RNA,通过 qRT-PCR 计算脂质代谢相关基因的表达。通过高通量测序评估肠道微生物群的变化。结果表明,FVP 和 FMT 补充剂对小鼠肥胖、高血脂和胰岛素抵抗有缓解作用。在 FVP 和 FMT 治疗组中均发现 Ampkα1 和 Ppara 的表达上调。FVP 和 FMT 分别引起肠道微生物群的不同变化。PICRUSt 分析表明,与 FVP 补充相比,FMT 对 HFD 喂养小鼠的脂质代谢调节具有显著影响。本研究结果表明,口服 FVP 或 FMT 可显著减轻 HFD 喂养小鼠的 MS 相关肥胖、高血脂和胰岛素抵抗,其有益作用可能通过不同方式调节脂质代谢和肠道微生物群。这些结果提高了对 FVP 作为益生元的功能活性的理解。